Stocksigma LogoStocksigma Logo

Ajooni Biotech Submits SEBI Regulation 74(5) Dematerialisation Certificate for Q2 FY27

Ajooni Biotech Limited submitted its compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the

Ajooni Biotech Submits SEBI Regulation 74(5) Dematerialisation Certificate for Q2 FY27

Ajooni Biotech Ltd 路 Others (Uncategorized) 路 15 Oct 2026, 5:41 pm

Ajooni Biotech Submits SEBI Regulation 74(5) Dematerialisation Certificate for Q2 FY27 Ajooni Biotech Limited submitted its compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th Sep'26. Issued by Registrar and Share Transfer Agent Cameo Corporate Services Limited on 6th Oct'26, the certificate confirms that securities received for dematerialisation during the period were duly processed, listed on relevant stock exchanges, and physical certificates were mutilated and cancelled within the prescribed timelines.

Original exchange filing (PDF)

More announcements from Ajooni Biotech Ltd

All Ajooni Biotech Ltd announcements